Developer docs
API playgroundTry for free, no card

Search company profiles

Catapult Ventures

Full company profile

uuid0006voq

Namestring
Catapult Ventures
Legal namestring
Catapult Venture Managers Ltd
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Catapult Ventures is an independent UK venture capital fund manager (legal entity: Catapult Venture Managers Ltd, authorised and regulated by the Financial Conduct Authority) founded in 1999 and headquartered in Pinchbeck, Spalding, with an additional office in Birmingham. The firm manages approximately £130m of capital across multiple discrete VC funds on behalf of public and private sector investors, including the GM&C Life Sciences Fund (£45m+ targeting life-sciences companies in Greater Manchester, Cheshire and Warrington), the £30m Catapult Growth Fund, the East Midlands Regional Venture Capital Fund (EMRVCF), and the Advantage Enterprise & Innovation Fund (AEIF), which provides equity tickets of up to £2m. Catapult has built a portfolio of more than 100 companies across life sciences, biotech, medtech, digital health, renewable energy, and technology, with disclosed exits delivering cash returns of 3.3x to 9.0x.

The business model is professional fund management: Catapult charges management fees and earns carried interest on successful exits. Its two customer segments are (i) institutional and public-sector LPs who commit capital to its funds, and (ii) entrepreneurs and business owners seeking growth equity. Catapult differentiates through deep regional and sector specialisation — particularly in life sciences — supported by an executive team and venture partners with 30+ years of private equity experience and prior operating roles at NatWest, AstraZeneca, and FTSE/AIM-listed boards. GTM is sales-led and network-driven, sourcing deals via industry relationships, university spin-outs (e.g., Keele University), and regional development mandates. Catapult has no proprietary technology product; its core deliverable is fund management expertise, deal selection, and portfolio company support.

Short descriptiontext

Catapult Ventures is a UK-regulated venture capital fund manager operating multiple discrete VC funds totalling c. £130m, investing growth equity of £50k-£2m into life-sciences and technology companies for institutional and public-sector limited partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSpalding, United Kingdom
HQ citystring
Spalding
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital funds, equity capital, fund management, growth capital, life sciences investment
Industry1 code
PRIMARYFSANAAAJ
Venture Capital Fund-of-Funds / Multi-Manager Platforms
NAICS code1 code
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital Fund Management
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Fund Management Fees
TypeProfessional Services
Description

Catapult Ventures generates revenue through managing venture capital funds on behalf of public and private sector investors. They operate multiple discrete VC funds totaling approximately £130m, charging management fees and potentially performance fees (carried interest) on successful exits.

catapult-ventures.com
2Investment Returns
TypeLicensing Royalties
Description

Returns from portfolio company exits including the sale of stakes in companies such as Panthera Biopartners (3.3x return), Yospace (6.7x return), Monica Healthcare (3.5x return), Silver Lining Solutions, Accutronics (9x cash return), and Oxford Cryosystems (5.2x cash return).

catapult-ventures.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1GM&C Life Sciences Fund
Description

A life sciences venture capital fund managed by Catapult Ventures, focused on investments in the Greater Manchester, Cheshire and Warrington region.

catapult-ventures.com
+3 more records
Core offering1 text field

Catapult Ventures is an independent fund manager that operates multiple discrete venture capital funds on behalf of public and private sector investors, totalling approximately £130m. The firm sources, invests in, and supports portfolio companies, primarily in life sciences and technology sectors, with equity tickets typically between £50,000 and £2m. Revenue is generated through fund management fees and returns from successful portfolio company exits.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Catapult Ventures is an independent Fund Manager operating multiple discrete venture capital funds on behalf of public and private sector investors, totalling approximately £130m. The company offers four distinct fund products: the GM&C Life Sciences Fund (focused on life sciences investments in Greater Manchester, Cheshire and Warrington), the Catapult Growth Fund (£30m fund for small/mid-market transactions), the East Midlands Regional Venture Capital Fund, and the Advantage Enterprise & Innovation Fund (for businesses seeking up to £2m equity funding).

Product and service2 records
1GM&C Life Sciences Fund
CategoryVenture Capital Fund
Description

A life sciences venture capital fund focused on investing in innovative companies in the Greater Manchester, Cheshire and Warrington region, managed by Catapult Ventures on behalf of public and private sector investors.

2Catapult Growth Fund
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Mercia Fund Management
TypeDirect peer
Description

UK regional fund manager operating multiple discrete equity funds across the Midlands and North of England, with comparable focus on early-growth and life sciences/tech investments via regional and sector vehicles.

TypeDirect peer
Description

UK fund manager running a multi-fund regional VC and private equity programme for SMEs, with similarly small-to-mid ticket sizes and a focus on regional economic development alongside commercial returns.

TypeDirect peer
Description

Manchester-based early-growth VC manager operating multiple funds investing across the North West of England; highly comparable geography, ticket size and sector mix (including life sciences and tech).

TypeDirect peer
Description

UK life sciences and technology-focused fund manager running multiple sector-specialised EIS/SEIS and growth funds, directly comparable to Catapult's GM&C Life Sciences Fund and Advantage Enterprise & Innovation Fund.

TypeDirect peer
Description

West Midlands-based fund manager delivering equity and debt finance to SMEs via multiple regional and sector funds, overlapping with Catapult's regional VC mandate and ticket sizes.

TypeBroad incumbent
Description

Larger UK-listed fund manager operating regional and sector VCT/EIS funds, including life sciences exposure; broader portfolio and scale but overlapping fund-of-funds-like multi-vehicle structure.

TypeBroad incumbent
Description

One of the UK's largest VCs, with multiple sector and regional funds and significant life sciences exposure via the Octopus Future Generations and specialist vehicles; competes for the same UK growth-stage companies.

TypeBroad incumbent
Description

Long-established UK fund manager running multiple VCT and growth funds, including life sciences exposure, with comparable multi-fund platform structure to Catapult.

TypeEmerging player
Description

Manchester-anchored growth and IP-led investment firm focused on university spinouts across the North of England; competes for similar regional life sciences and deep-tech opportunities as Catapult's GM&C Life Sciences Fund.

TypeRegional player
Description

South Yorkshire-based fund management business delivering equity and debt finance to SMEs via regional and sector funds; comparable regional VC mandate and ticket size to Catapult's funds.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment103 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Catapult Ventures

Venture Capital Fund Managementcatapult-ventures.com

Catapult Ventures is a UK-regulated venture capital fund manager operating multiple discrete VC funds totalling c. £130m, investing growth equity of £50k-£2m into life-sciences and technology companies for institutional and public-sector limited partners.

What Catapult Ventures does

Catapult Ventures is an independent UK venture capital fund manager (legal entity: Catapult Venture Managers Ltd, authorised and regulated by the Financial Conduct Authority) founded in 1999 and headquartered in Pinchbeck, Spalding, with an additional office in Birmingham. The firm manages approximately £130m of capital across multiple discrete VC funds on behalf of public and private sector investors, including the GM&C Life Sciences Fund (£45m+ targeting life-sciences companies in Greater Manchester, Cheshire and Warrington), the £30m Catapult Growth Fund, the East Midlands Regional Venture Capital Fund (EMRVCF), and the Advantage Enterprise & Innovation Fund (AEIF), which provides equity tickets of up to £2m. Catapult has built a portfolio of more than 100 companies across life sciences, biotech, medtech, digital health, renewable energy, and technology, with disclosed exits delivering cash returns of 3.3x to 9.0x.

The business model is professional fund management: Catapult charges management fees and earns carried interest on successful exits. Its two customer segments are (i) institutional and public-sector LPs who commit capital to its funds, and (ii) entrepreneurs and business owners seeking growth equity. Catapult differentiates through deep regional and sector specialisation — particularly in life sciences — supported by an executive team and venture partners with 30+ years of private equity experience and prior operating roles at NatWest, AstraZeneca, and FTSE/AIM-listed boards. GTM is sales-led and network-driven, sourcing deals via industry relationships, university spin-outs (e.g., Keele University), and regional development mandates. Catapult has no proprietary technology product; its core deliverable is fund management expertise, deal selection, and portfolio company support.

Catapult Ventures firmographics

Firmographics
Name
Catapult Ventures
Legal name
Catapult Venture Managers Ltd
Website
https://catapult-ventures.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
Catapult Ventures is a UK-regulated venture capital fund manager operating multiple discrete VC funds totalling c. £130m, investing growth equity of £50k-£2m into life-sciences and technology companies for institutional and public-sector limited partners.
Ownership category
akta.pro rank

Catapult Ventures industry classification

Industry
Product category
Venture Capital Fund Management
NAICS
Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAJ
Venture Capital Fund-of-Funds / Multi-Manager Platforms

Keywords

  • Venture capital funds
  • Equity capital
  • Fund management
  • Growth capital
  • Life sciences investment

Where Catapult Ventures is headquartered

Location

Headquarters

HQ city
Spalding
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Catapult Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Fund Management Fees: Catapult Ventures generates revenue through managing venture capital funds on behalf of public and private sector investors. They operate multiple discrete VC funds totaling approximately £130m, charging management fees and potentially performance fees (carried interest) on successful exits.
  2. Investment Returns: Returns from portfolio company exits including the sale of stakes in companies such as Panthera Biopartners (3.3x return), Yospace (6.7x return), Monica Healthcare (3.5x return), Silver Lining Solutions, Accutronics (9x cash return), and Oxford Cryosystems (5.2x cash return).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Catapult Ventures product offering

Product offering

Core offering

Catapult Ventures is an independent fund manager that operates multiple discrete venture capital funds on behalf of public and private sector investors, totalling approximately £130m. The firm sources, invests in, and supports portfolio companies, primarily in life sciences and technology sectors, with equity tickets typically between £50,000 and £2m. Revenue is generated through fund management fees and returns from successful portfolio company exits.

Product overview

Catapult Ventures is an independent Fund Manager operating multiple discrete venture capital funds on behalf of public and private sector investors, totalling approximately £130m. The company offers four distinct fund products: the GM&C Life Sciences Fund (focused on life sciences investments in Greater Manchester, Cheshire and Warrington), the Catapult Growth Fund (£30m fund for small/mid-market transactions), the East Midlands Regional Venture Capital Fund, and the Advantage Enterprise & Innovation Fund (for businesses seeking up to £2m equity funding).

Differentiator

Problem solved

Functional benefit

Brands

  • GM&C Life Sciences Fund: A life sciences venture capital fund managed by Catapult Ventures, focused on investments in the Greater Manchester, Cheshire and Warrington region.
  • Catapult Growth Fund
  • East Midlands Regional Venture Capital Fund (EMRVCF)
  • Advantage Enterprise & Innovation Fund (AEIF)

Products and services

  • GM&C Life Sciences Fund A life sciences venture capital fund focused on investing in innovative companies in the Greater Manchester, Cheshire and Warrington region, managed by Catapult Ventures on behalf of public and private sector investors.
  • Catapult Growth Fund

Companies that use Catapult Ventures

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Catapult Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Catapult Ventures partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves6 records

Expansion highlights4 records

Catapult Ventures competitors and assessment

Company assessment

Direct peers

  • Mercia Fund Management: UK regional fund manager operating multiple discrete equity funds across the Midlands and North of England, with comparable focus on early-growth and life sciences/tech investments via regional and sector vehicles.
  • Maven Capital Partners: UK fund manager running a multi-fund regional VC and private equity programme for SMEs, with similarly small-to-mid ticket sizes and a focus on regional economic development alongside commercial returns.
  • Praetura Ventures: Manchester-based early-growth VC manager operating multiple funds investing across the North West of England; highly comparable geography, ticket size and sector mix (including life sciences and tech).
  • Deepbridge Capital: UK life sciences and technology-focused fund manager running multiple sector-specialised EIS/SEIS and growth funds, directly comparable to Catapult's GM&C Life Sciences Fund and Advantage Enterprise & Innovation Fund.
  • Midven (Midlands Engine Investment Fund): West Midlands-based fund manager delivering equity and debt finance to SMEs via multiple regional and sector funds, overlapping with Catapult's regional VC mandate and ticket sizes.

Broad incumbents

  • Foresight Group: Larger UK-listed fund manager operating regional and sector VCT/EIS funds, including life sciences exposure; broader portfolio and scale but overlapping fund-of-funds-like multi-vehicle structure.
  • Octopus Ventures: One of the UK's largest VCs, with multiple sector and regional funds and significant life sciences exposure via the Octopus Future Generations and specialist vehicles; competes for the same UK growth-stage companies.
  • Albion Capital Group: Long-established UK fund manager running multiple VCT and growth funds, including life sciences exposure, with comparable multi-fund platform structure to Catapult.

Emerging players

  • Northern Gritstone: Manchester-anchored growth and IP-led investment firm focused on university spinouts across the North of England; competes for similar regional life sciences and deep-tech opportunities as Catapult's GM&C Life Sciences Fund.

Regional players

  • Whiterose Finance: South Yorkshire-based fund management business delivering equity and debt finance to SMEs via regional and sector funds; comparable regional VC mandate and ticket size to Catapult's funds.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Catapult Ventures social profiles

Digital presence

Catapult Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Catapult Ventures leadership team

Management profile

Number of profiles

Profiles1 record

Catapult Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Catapult Ventures M&A and investment

M&A and investment

M&A4 records

Investments103 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Catapult Ventures

What does Catapult Ventures do?

Catapult Ventures is an independent fund manager that operates multiple discrete venture capital funds on behalf of public and private sector investors, totalling approximately £130m. The firm sources, invests in, and supports portfolio companies, primarily in life sciences and technology sectors, with equity tickets typically between £50,000 and £2m. Revenue is generated through fund management fees and returns from successful portfolio company exits.

Is Catapult Ventures a public or private company?

Catapult Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Catapult Ventures founded?

Catapult Ventures was founded in 1999. It employs 11 to 50 people.

Where is Catapult Ventures based?

Catapult Ventures is headquartered in Spalding, United Kingdom, in the Europe region.

How does Catapult Ventures make money?

Two revenue lines are on record. Fund Management Fees are the primary driver. The others are investment Returns.

Who are Catapult Ventures's main competitors?

Direct peers on record are Mercia Fund Management, Maven Capital Partners, Praetura Ventures, Deepbridge Capital and Midven (Midlands Engine Investment Fund). Broad incumbents are Foresight Group, Octopus Ventures and Albion Capital Group. Northern Gritstone is listed as an emerging player. Whiterose Finance is listed as a regional player.

Does Catapult Ventures have an API?

No public API is recorded for Catapult Ventures.

What industry is Catapult Ventures in?

Catapult Ventures's product category is Venture Capital Fund Management. Its primary akta.pro industry code is FSANAAAJ, Venture Capital Fund-of-Funds / Multi-Manager Platforms. Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Tracxn2026 Funding Rounds & List of InvestorsElroy Air has raised multiple funding rounds from 2017 to 2024, including a Series B in October 2024 and a Series B in January 2024. The rounds range from seed to Series B, with lead investors including Precursor Ventures, Catapult Ventures, and others.Venture Capital Access OnlineArray Labs Raises Additional $21M, Anchored by Strategic Investment from Mitsubishi ElectricArray Labs raised $21 million in a strategic investment round anchored by Mitsubishi Electric, with participation from Catapult Ventures, Kompas VC, and Y Combinator. The companies will develop satellite-based maritime and aircraft tracking services for defense and security customers in the Asia Pacific region. Array Labs has validated its core formation flying and multistatic technology.FinSMEsArray Labs Raises Additional $21M in FundingArray Labs raised $21M in funding, anchored by Mitsubishi Electric, to develop radar satellites for maritime and aircraft tracking. The company, led by Andrew Peterson, has validated its formation-flying technology and secured DARPA, Navy, and Air Force contracts.PR NewswireArray Labs Raises Additional $21M, Anchored by Strategic Investment from Mitsubishi ElectricArray Labs raised $21 million in a strategic investment round anchored by Mitsubishi Electric, with participation from Catapult Ventures, Kompas VC, and Y Combinator. The companies will develop satellite-based maritime and aircraft tracking services for defense and security customers in Asia Pacific. The partnership follows Array's Series A fundraise in January 2026.UKTNManchester-based medical device startup lands £735K funding to treat brain tumoursManchester-based medical device startup QV Bioelectronics has secured £735,000 in an oversubscribed seed funding round to advance the development of its GRACE implant for treating glioblastoma. The investment was led by Consilience Ventures, SOSV, and the GM & Cheshire Life Sciences Fund managed by Catapult Ventures, with additional support from angel investors. These funds will be used to expand the company's team and further develop the electric field therapy technology before it enters clinical trials.BusinessCloudIntelligent healthtech firm gets funding injectionRinicare, a Macclesfield-based digital healthcare firm, raised funding from Catapult Ventures and NPIF to commercialize its PRIME and SAFE wireless healthcare solutions. The company will also develop its AI-powered Stability intensive care system, targeting a market projected to reach $24.6 billion by 2022.FinSMEsIntelligent Healthcare Company Rinicare Completes FinancingRinicare, a Manchester-based intelligent healthcare company, completed a financing round with new investors Catapult Ventures and NPIF – Mercia Equity Finance. The funds will support commercializing its digital healthcare portfolio and advancing its AI-powered predictive algorithm for intensive care.NewswireIntelligent Healthcare Company Rinicare Announces Completion of FinancingRinicare completed a financing round with Catapult Ventures and NPIF - Mercia Equity Finance. The funds will support commercialization of its PRIME and SAFE wireless healthcare solutions and development of its AI-intensive care system, Stability. The AI market is projected to reach $24.6 billion by 2022.FinSMEsLumora Raises £1.5M in Series B FundingLumora, a UK molecular diagnostics firm, raised £1.5M in Series B funding led by Catapult Benture Managers. The company will use the funds to accelerate its entry into clinical molecular diagnostics, developing GI infection testing and HIV viral load monitoring systems.FinSMEsYospace Enterprises Raises £600,000 from Catapult Venture ManagersYospace Enterprises, a UK-based mobile video platform developer, raised £600,000 from Catapult Venture Managers. The funding will accelerate growth of its yospaceCDS technology, used by blue-chip customers. CEO Tim Sewell said the investment helps establish the company as a market leader in mobile video.